Rigel Pharmaceuticals, Inc. · NASDAQ:RIGL
Ali-Jackson Kamil sold 2,500 Rigel Pharmaceuticals, Inc. shares (Form 4)
Traded May 26, 2026 · Filed May 28, 2026
On May 26, 2026, Ali-Jackson Kamil (Director) sold 2,500 Rigel Pharmaceuticals, Inc. shares at US$29.17 for US$72,925 under a trading plan, leaving 12,625 shares. Filed May 28, 2026 (Form 4).
- Sold
- 2,500 shares
- Price
- US$29.17
- Value
- US$72,925
- Holding after
- 12,625 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| May 26, 2026 | Common Stock | Sale | 2,500 | US$29.17 | 12,625 | Direct |
Source
Related
- Rigel Pharmaceuticals, Inc.
- Ali-Jackson Kamil
- Rigel Pharmaceuticals, Inc. shareholders
- Form 4 · Ali-Jackson Kamil · Jun 24, 2026
- Form 4 · Ali-Jackson Kamil · May 19, 2026
- Form 4 · Schorno Dean L · Sep 3, 2026
- Form 4 · Santos David A · Sep 3, 2026
- Form 4 · Rodriguez Raul R · Sep 3, 2026
- Form 4 · Furey Raymond J. · Sep 3, 2026
- Schedule 13G/A · Armistice Capital, LLC · Aug 14, 2026